Uses of Dolojust 50 mg/500 mg Tablet
Dolojust 50 mg/500 mg Tablet is used for the treatment or prevention of the following disease(s):
Pain Relief, Rheumatoid Arthritis
Side effects of Dolojust 50 mg/500 mg Tablet
Precautions while taking Dolojust 50 mg/500 mg Tablet
Dosage of Dolojust 50 mg/500 mg Tablet
Overdose of Dolojust 50 mg/500 mg Tablet
Onset of Action of Dolojust 50 mg/500 mg Tablet
Duration of Action of Dolojust 50 mg/500 mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Dolojust 50 mg/500 mg Tablet
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
acetaminophen: Increased risk of adverse renal effects with long-term concurrent use.
anticoagulants, thrombolytics: Prolonged PT, increased risk of bleeding.
antihypertensives: Decreased antihypertensive effectiveness.
aspirin, other NSAIDs, salicylates: Increased GI irritability and bleeding, decreased diclofenac effectiveness.
beta blockers: Impaired antihypertensive effect.
cefamandole, cefoperazone, cefotetan, plicamycin, valproic acid: Increased risk of hypoprothrombinemia.
cimetidine: Altered blood diclofenac level.
colchicine, corticotropin long-term use, glucocorticoids, potassium supplements:Increased GI irritability and bleeding.
cyclosporine, gold compounds, nephrotoxic drugs: Increased risk of nephrotoxicity.
digoxin: Increased blood digoxin level.
insulin, oral antidiabetics: Decreased effects of these drugs.
lithium: Increased risk of lithium toxicity.
loop diuretics: Decreased diuretic effects.
methotrexate: Increased risk of methotrexate toxicity.
phenytoin: Increased blood phenytoin level potassium-sparing diuretics: Increased risk of hyperkalemia.
probenecid: Increased diclofenac toxicity.
Food :-
food: Delayed absorption of delayed-release tablets.
Activity :-
alcohol use: Increased risk of GI irritability and bleeding.
Kunal is a registered pharmacist with RGUHS with over 4 years experience. He is a medicine content contributor at Health-Shoppe.com.
Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the management of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.